Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $4.8 million.

  • Healthequity's Net Cash Flow rose 20143.76% to $4.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$12.9 million, marking a year-over-year decrease of 845.52%. This contributed to the annual value of -$108.0 million for FY2025, which is 17215.87% down from last year.
  • Latest data reveals that Healthequity reported Net Cash Flow of $4.8 million as of Q4 2025, which was up 20143.76% from $16.6 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Net Cash Flow peaked at $408.0 million during Q2 2021, and registered a low of -$423.7 million during Q1 2022.
  • For the 5-year period, Healthequity's Net Cash Flow averaged around $495150.0, with its median value being $16.1 million (2022).
  • As far as peak fluctuations go, Healthequity's Net Cash Flow surged by 207726.94% in 2021, and later crashed by 153890.72% in 2022.
  • Quarter analysis of 5 years shows Healthequity's Net Cash Flow stood at -$104.6 million in 2021, then soared by 131.84% to $33.3 million in 2022, then surged by 31.24% to $43.7 million in 2023, then crashed by 110.82% to -$4.7 million in 2024, then surged by 201.44% to $4.8 million in 2025.
  • Its Net Cash Flow stands at $4.8 million for Q4 2025, versus $16.6 million for Q3 2025 and -$8.1 million for Q2 2025.